PURE (PURE Bioscience) Accounts Payable: $0.72 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PURE Bioscience Accounts Payable?

PURE Bioscience PURE +13.17% Accounts Payable is $0.72 Mil as of Apr. 2026. The stock has 5 warning signs investors should review.

PURE Bioscience's Accounts Payable for the quarter that ended in Apr. 2026 was $0.72 Mil.

PURE Bioscience's quarterly Accounts Payable declined from Oct. 2025 ($0.88 Mil) to Jan. 2026 ($0.77 Mil) and declined from Jan. 2026 ($0.77 Mil) to Apr. 2026 ($0.72 Mil).

PURE Bioscience's annual Accounts Payable increased from Jul. 2023 ($0.42 Mil) to Jul. 2024 ($0.60 Mil) and increased from Jul. 2024 ($0.60 Mil) to Jul. 2025 ($0.78 Mil).

PURE Bioscience Accounts Payable Related Terms

PURE Bioscience Accounts Payable Historical Data

* Premium members only.

The historical data trend for PURE Bioscience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PURE Bioscience Accounts Payable Chart

PURE Bioscience Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.49 0.42 0.60 0.78

PURE Bioscience Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.78 0.88 0.77 0.72

PURE Bioscience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.72 Mil mean?
PURE Bioscience (PURE) has a Accounts Payable of $0.72 Mil as of Apr. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PURE Bioscience and its competitors.
Is PURE Bioscience's Accounts Payable too high?
PURE Bioscience's current Accounts Payable is $0.72 Mil.
How does PURE Bioscience's Accounts Payable compare to DQWS and RAY?
PURE Bioscience's Accounts Payable of $0.72 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PURE Bioscience and its competitors. PURE Bioscience's current Accounts Payable is $0.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current Accounts Payable is $0.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PURE Bioscience (PURE), the current Accounts Payable is $0.72 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PURE Bioscience Business Description

Address 771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.